HOME › DRUGS › SITAGLIPTIN;METFORMIN HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

SITAGLIPTIN;METFORMIN HYDROCHLORIDE

Brand name(s): Sitagliptin / Metformin hydrochloride Sun, Ristfor, Sitagliptin / Metformin hydrochloride Accord
EMA LISTED
LAPSED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Sitagliptin;Metformin Hydrochloride
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V., Sun Pharmaceutical Industries Europe B.V., Accord Healthcare S.L.U.
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RistforMerck Sharp & Dohme B.V.Authorised15/03/2010Diabetes Mellitus, Type 2
Sitagliptin / Metformin hydrochloride AccordAccord Healthcare S.L.U.Lapsed22/07/2022Diabetes Mellitus, Type 2
Sitagliptin / Metformin hydrochloride SunSun Pharmaceutical Industries Europe B.V.Authorised31/03/2023Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON SITAGLIPTIN;METFORMIN HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →